Karen A. Dawes, Director at REPLIGEN CORP (RGEN), sold 274 shares at $295.02 ($81K) on 2021-09-14, disclosed to the SEC on 2021-09-15.
Open-market sale of $81k RGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $290.02 | 13 | $4K | 4.7% |
| 2 | $292.34 | 25 | $7K | 9.1% |
| 3 | $294.06 | 101 | $30K | 36.8% |
| 4 | $295.02 | 108 | $32K | 39.5% |
| 5 | $295.82 | 27 | $8K | 9.9% |
| Total | $294.26 avg | 274 |
| $81K |
| 100% |
| Filing → |
| RGEN | SELL | 2023-08-30 | $146K | — | Filing → |
| RGEN | SELL | 2022-09-09 | $352K | — | Filing → |
| RGEN | SELL | 2022-05-26 | $4.4M | — | Filing → |